Hospital Universitario Ramón y Cajal

Public research footprint of Hospital Universitario Ramón y Cajal, compiled from the ClinicalTrials.gov public registry.

549

Registered studies

217

Active

122

Recruiting now

233

Completed

Stopped or withdrawn

Most-studied conditions

Metastatic Castration Sensitive Prostate Cancer (mCSPC) · Triple-Negative Breast Cancer · Clostridium Difficile Infection Recurrence · Clostridioides Difficile Infection Recurrence

Recently updated registry entries

NCT05217446 — A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to… (Active Not Recruiting)
NCT04554914 — A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV)… (Active Not Recruiting)
NCT04996875 — (Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Hospital Universitario Ramón y Cajal?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.